Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$304.11 - $351.99 $2,432 - $2,815
8 Added 0.61%
1,316 $455,000
Q4 2023

Feb 14, 2024

SELL
$269.37 - $365.04 $332,941 - $451,189
-1,236 Reduced 48.58%
1,308 $422,000
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $390,765 - $528,716
-1,087 Reduced 29.94%
2,544 $964,000
Q1 2023

May 12, 2023

SELL
$418.69 - $503.0 $54,848 - $65,893
-131 Reduced 3.48%
3,631 $1.74 Million
Q3 2022

Nov 08, 2022

BUY
$412.59 - $563.26 $11,139 - $15,208
27 Added 0.75%
3,637 $1.52 Million
Q2 2022

Aug 08, 2022

BUY
$463.67 - $597.16 $565,213 - $727,938
1,219 Added 50.98%
3,610 $1.79 Million
Q1 2022

May 17, 2022

SELL
$524.57 - $735.42 $112,782 - $158,115
-215 Reduced 8.25%
2,391 $1.35 Million
Q4 2021

Feb 15, 2022

SELL
$708.84 - $794.68 $161,615 - $181,187
-228 Reduced 8.05%
2,606 $1.97 Million
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $416,988 - $523,538
-634 Reduced 18.28%
2,834 $2.11 Million
Q2 2021

Jul 30, 2021

BUY
$576.64 - $649.04 $119,364 - $134,351
207 Added 6.35%
3,468 $2.23 Million
Q1 2021

May 07, 2021

SELL
$547.01 - $662.35 $1.17 Million - $1.41 Million
-2,131 Reduced 39.52%
3,261 $1.86 Million
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $113,370 - $142,845
-222 Reduced 3.95%
5,392 $3.14 Million
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $47,260 - $55,702
-104 Reduced 1.82%
5,614 $2.89 Million
Q2 2020

Aug 12, 2020

SELL
$334.87 - $493.06 $102,470 - $150,876
-306 Reduced 5.08%
5,718 $2.58 Million
Q1 2020

May 15, 2020

BUY
$320.01 - $409.07 $137,604 - $175,900
430 Added 7.69%
6,024 $2.11 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $798,365 - $934,377
2,497 Added 80.63%
5,594 $2.07 Million
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $264,958 - $300,358
870 Added 39.07%
3,097 $1.03 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $328,534 - $357,915
-1,145 Reduced 33.96%
2,227 $696,000
Q1 2019

May 15, 2019

SELL
$224.3 - $317.41 $493,684 - $698,619
-2,201 Reduced 39.49%
3,372 $1.03 Million
Q4 2018

Jan 31, 2019

SELL
$220.1 - $309.0 $372,849 - $523,446
-1,694 Reduced 23.31%
5,573 $1.29 Million
Q3 2018

Nov 15, 2018

SELL
$289.28 - $326.15 $1.02 Million - $1.15 Million
-3,528 Reduced 32.68%
7,267 $2.27 Million
Q2 2018

Aug 22, 2018

SELL
$244.1 - $303.88 $12.9 Million - $16 Million
-52,781 Reduced 83.02%
10,795 $3.12 Million
Q2 2018

Aug 15, 2018

BUY
$244.1 - $303.88 $12 Million - $14.9 Million
49,037 Added 337.28%
63,576 $3.12 Million
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $374,352 - $438,576
-1,600 Reduced 9.91%
14,539 $3.93 Million
Q4 2017

Feb 13, 2018

SELL
$216.94 - $271.3 $631,729 - $790,025
-2,912 Reduced 15.29%
16,139 $3.85 Million
Q3 2017

Nov 07, 2017

BUY
$212.27 - $242.28 $4.04 Million - $4.62 Million
19,051
19,051 $4.23 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.38B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.